Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 1/2016

01-01-2016 | Editorial

From Prague to Seattle: Improved Endoscopic Technique and Reporting Improves Outcomes in Patients with Barrett’s Esophagus

Authors: J. Brown, P. Sharma

Published in: Digestive Diseases and Sciences | Issue 1/2016

Login to get access

Excerpt

Endoscopic screening and surveillance practices in patients with Barrett’s esophagus (BE) remain controversial. No randomized, controlled trials have supported decreased mortality as a result of these programs, but given evidence from cohort and retrospective studies combined with the rapidly rising incidence of esophageal adenocarcinoma (EAC), some GI societies have weakly recommended screening and surveillance endoscopy for BE patients [1]. The goal of the initial endoscopy is to detect BE and, if detected, to grade and evaluate for the presence of dysplasia and EAC. …
Literature
1.
Wang, et al. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s Esophagus. Am J Gastroenterol. 2008;103:788–797.PubMedCrossRef
2.
Visrodia K, Iyer PG, Schleck CD, Zinsmeister AR, Katzka DA. Yield of repeat endoscopy in Barrett’s esophagus with no dysplasia and low-grade dysplasia: a population-based study. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-015-3697-6.
3.
Singh M, et al. Practice patterns among US gastroenterologists regarding endoscopic management of Barrett’s esophagus. Gastrointest Endosc. 2013;78:689–695.PubMedCrossRef
4.
Gupta, et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76:531–538.PubMedCrossRef
5.
Sharma P, et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett’s esophagus. Gastrointest Endosc. 2006;64:167–175.PubMedCrossRef
6.
Peters FP, et al. Surveillance history of endoscopically treated patients with early Barrett’s neoplasia: nonadherence to the Seattle protocol leads to sampling error. Dis Esophagus. 2008;21:475–479.PubMedCrossRef
7.
Rein BJ, et al. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol. 2000;95:3089–3096.CrossRef
8.
9.
Abdalla M, et al. Dysplasia detection rate of confirmatory EGD in nondysplastic Barrett’s esophagus. Dis Esophagus. 2014;27:505–510.PubMedCrossRef
10.
Abrams JA, et al. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clinical Gastroenterol Hepatol. 2009;7:736–742.CrossRef
11.
Curvers, et al. Quality of Barrett’s surveillance in the Netherlands: a standardized review of endoscopy and pathology reports. Eur J Gastroenterol Hepatol. 2008;20:601–607.PubMedCrossRef
Metadata
Title
From Prague to Seattle: Improved Endoscopic Technique and Reporting Improves Outcomes in Patients with Barrett’s Esophagus
Authors
J. Brown
P. Sharma
Publication date
01-01-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3958-4

Other articles of this Issue 1/2016

Digestive Diseases and Sciences 1/2016 Go to the issue

Original Article

Correlation Between Capillary and Venous Blood Glucose in the Lactose Tolerance Test

Original Article

Endoscopic Retrograde Cholangiopancreatography in Patients with Previous Pancreaticoduodenectomy: A Single-Center Experience

Original Article

Yield of Repeat Endoscopy in Barrett’s Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study

Original Article

Population, Epidemiological, and Functional Genetics of Gastric Cancer Candidate Genes in Peruvians with Predominant Amerindian Ancestry

Original Article

Percutaneous Microwave Ablation in the Spleen for Treatment of Hypersplenism in Cirrhosis Patients

Original Article

Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits